Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Immunologiske mekanismer for drap av kreftceller.

Schjesvold FH.

Tidsskr Nor Laegeforen. 2017 Jan 10;137(1):58. doi: 10.4045/tidsskr.16.0963. eCollection 2017 Jan. Norwegian. No abstract available.

PMID:
28073239
Free Article
2.

Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial.

Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, Nyquist E, Dalgaard J, Meyer P, Lehmann AK, Hammerstrøm J, Skjelbakken T, Høiby EA, Sandvik L, Kvaløy S.

Clin Microbiol Infect. 2017 Mar;23(3):179-187. doi: 10.1016/j.cmi.2016.10.019. Epub 2016 Oct 26.

PMID:
27793737
3.

Indirect CD4+ T-cell-mediated elimination of MHC II(NEG) tumor cells is spatially restricted and fails to prevent escape of antigen-negative cells.

Tveita AA, Schjesvold FH, Sundnes O, Haabeth OA, Haraldsen G, Bogen B.

Eur J Immunol. 2014 Sep;44(9):2625-37. doi: 10.1002/eji.201444659. Epub 2014 Jun 20.

4.

Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators.

N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.

5.

[Investigation of amyloidosis].

Schjesvold FH.

Tidsskr Nor Laegeforen. 2013 Feb 5;133(3):266. doi: 10.4045/tidsskr.13.0044. Norwegian. No abstract available.

6.

A woman in her seventies with reduced general condition, dyspnoea and generalised pain.

Tazmini K, Bakken HN, Schjesvold FH.

Tidsskr Nor Laegeforen. 2012 Sep 18;132(17):1969-72. English, Norwegian. No abstract available. Erratum in: Tidsskr Nor Laegeforen. 2012 Oct 30;132(20):2260.

7.

[Erythrocytosis as a problem].

Schjesvold FH.

Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2387; author reply 2387. doi: 10.4045/tidsskr.09.1196. Norwegian. No abstract available.

8.

[High-dose treatment of systemic AL-amyloidosis with autologous stem cell support].

Schjesvold FH, Sjo M, Tangen JM, Hammerstrøm J, Brinch L.

Tidsskr Nor Laegeforen. 2008 Jun 12;128(12):1392-6. Norwegian.

Supplemental Content

Loading ...
Support Center